Epithelial IL-23R signaling licenses protective IL-22 responses in intestinal inflammation by Aden, Konrad et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Epithelial IL-23R signaling licenses protective IL-22 responses in intestinal
inflammation
Aden, Konrad; Rehman, Ateequr; Falk-Paulsen, Maren; Secher, Thomas; Kuiper, Jan; Tran, Florian;
Pfeuffer, Steffen; Sheibani-Tezerji, Raheleh; Breuer, Alexandra; Luzius, Anne; Jentzsch, Marlene;
Häsler, Robert; Billmann-Born, Susanne; Will, Olga; Lipinski, Simone; Bharti, Richa; Adolph, Timon;
Iovanna, Juan L; Kempster, Sarah L; Blumberg, Richard S; Schreiber, Stefan; Becher, Burkhard;
Chamaillard, Mathias; Kaser, Arthur; Rosenstiel, Philip
Abstract: A plethora of functional and genetic studies have suggested a key role for the IL-23 path-
way in chronic intestinal inflammation. Currently, pathogenic actions of IL-23 have been ascribed to
specific effects on immune cells. Herein, we unveil a protective role of IL-23R signaling. Mice deficient
in IL-23R expression in intestinal epithelial cells (Il23R(ΔIEC)) have reduced Reg3b expression, show
a disturbed colonic microflora with an expansion of flagellated bacteria, and succumb to DSS colitis.
Surprisingly, Il23R(ΔIEC) mice show impaired mucosal IL-22 induction in response to IL-23. ￿Thy-
1 treatment significantly deteriorates colitis in Il23R(ΔIEC) animals, which can be rescued by IL-22
application. Importantly, exogenous Reg3b administration rescues DSS-treated Il23R(ΔIEC) mice by
recruiting neutrophils as IL-22-producing cells, thereby restoring mucosal IL-22 levels. The study iden-
tifies a critical barrier-protective immune pathway that originates from, and is orchestrated by, IL-23R
signaling in intestinal epithelial cells.
DOI: https://doi.org/10.1016/j.celrep.2016.07.054
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-129052
Published Version
 
 
Originally published at:
Aden, Konrad; Rehman, Ateequr; Falk-Paulsen, Maren; Secher, Thomas; Kuiper, Jan; Tran, Florian;
Pfeuffer, Steffen; Sheibani-Tezerji, Raheleh; Breuer, Alexandra; Luzius, Anne; Jentzsch, Marlene; Häsler,
Robert; Billmann-Born, Susanne; Will, Olga; Lipinski, Simone; Bharti, Richa; Adolph, Timon; Iovanna,
Juan L; Kempster, Sarah L; Blumberg, Richard S; Schreiber, Stefan; Becher, Burkhard; Chamaillard,
Mathias; Kaser, Arthur; Rosenstiel, Philip (2016). Epithelial IL-23R signaling licenses protective IL-22
responses in intestinal inflammation. Cell Reports, 16(8):2208-2218.
DOI: https://doi.org/10.1016/j.celrep.2016.07.054
Article
Epithelial IL-23R Signaling Licenses Protective IL-22
Responses in Intestinal Inflammation
Graphical Abstract
Highlights
d IL-23R transduces signals into the intestinal epithelium
d Il23RDIEC mice are susceptible to DSS colitis and have a
disturbed gut microflora
d Epithelial IL-23R is required for optimal secretion of the c-
type lectin Reg3b
d The c-type lectin Reg3b promotes recruitment of IL-22-
producing cells as an alarmin
d Systemic substitution of Reg3b rescues the gut barrier defect
of Il23RDIEC mice
Authors
Konrad Aden, Ateequr Rehman, Maren
Falk-Paulsen, ..., Mathias Chamaillard,
Arthur Kaser, Philip Rosenstiel
Correspondence
p.rosenstiel@mucosa.de
In Brief
Aden et al. show that epithelial IL-23R
signaling initiates a Reg3b-dependent
chemoattraction of IL-22-producing
neutrophil granulocytes into the intestinal
lamina propria, limiting flagellated
bacteria content and intestinal
inflammation.
Aden et al., 2016, Cell Reports 16, 2208–2218
August 23, 2016 ª 2016 The Authors.
http://dx.doi.org/10.1016/j.celrep.2016.07.054
Cell Reports
Article
Epithelial IL-23R Signaling Licenses Protective
IL-22 Responses in Intestinal Inflammation
Konrad Aden,1,2 Ateequr Rehman,1 Maren Falk-Paulsen,1 Thomas Secher,3 Jan Kuiper,1 Florian Tran,1 Steffen Pfeuffer,1
Raheleh Sheibani-Tezerji,1 Alexandra Breuer,1 Anne Luzius,1 Marlene Jentzsch,1 Robert Ha¨sler,1
Susanne Billmann-Born,1 Olga Will,1 Simone Lipinski,1 Richa Bharti,1 Timon Adolph,4 Juan L. Iovanna,5
Sarah L. Kempster,4 Richard S. Blumberg,6 Stefan Schreiber,1,2 Burkhard Becher,7 Mathias Chamaillard,8 Arthur Kaser,4
and Philip Rosenstiel1,9,*
1Institute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel,
24105 Kiel, Germany
2First Medical Department, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
3University Toulouse, CNRS, Inserm, CHU Toulouse, UMR 1043-UMR 5282, Centre de Physiopathologie Toulouse Purpan,
31024 Toulouse, France
4Division of Gastroenterology and Hepatology, Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge
CB2 0QQ, England, UK
5Aix-Marseille University, Institut Paoli-Calmettes, CNRS, Inserm, UMR 1068-UMR 7258, Centre de Recherche en Carce´rologie deMarseille,
13273 Marseille, France
6Gastroenterology Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
7Institute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland
8University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204–CIIL, Centre d’Infection et d’Immunite´ de Lille,
59000 Lille, France
9Lead Contact
*Correspondence: p.rosenstiel@mucosa.de
http://dx.doi.org/10.1016/j.celrep.2016.07.054
SUMMARY
A plethora of functional and genetic studies have
suggested a key role for the IL-23 pathway in chronic
intestinal inflammation. Currently, pathogenic ac-
tions of IL-23 have been ascribed to specific effects
on immune cells. Herein, we unveil a protective role
of IL-23R signaling. Mice deficient in IL-23R expres-
sion in intestinal epithelial cells (Il23RDIEC) have re-
duced Reg3b expression, show a disturbed colonic
microflora with an expansion of flagellated bacteria,
and succumb to DSS colitis. Surprisingly, Il23RDIEC
mice show impaired mucosal IL-22 induction in
response to IL-23. aThy-1 treatment significantly de-
teriorates colitis in Il23RDIEC animals, which can be
rescued by IL-22 application. Importantly, exoge-
nous Reg3b administration rescues DSS-treated
Il23RDIEC mice by recruiting neutrophils as IL-22-pro-
ducing cells, thereby restoring mucosal IL-22 levels.
The study identifies a critical barrier-protective im-
mune pathway that originates from, and is orches-
trated by, IL-23R signaling in intestinal epithelial
cells.
INTRODUCTION
Interleukin-23 (IL-23) is a heterodimeric cytokine of the IL-12 su-
perfamily, consisting of two subunits, IL-23p19 and IL-12p40,
and exerts important functions on T cell-driven immune re-
sponses in several organ systems (Parham et al., 2002). Over-
whelming genetic and functional evidence has pointed to
a pro-inflammatory role of the IL-23/IL-23 receptor (IL-23R)
signaling pathway in inflammatory bowel disease (IBD) and other
immune diseases (Croxford et al., 2012). Inhibition of IL-23
signaling has been shown to ameliorate several murine models
of intestinal inflammation (Elson et al., 2007). So far, the pro-in-
flammatory effects of IL-23 have been ascribed to perpetuating
pathogenic TH17 responses, with increased production of the
TH17-associated cytokines IL-17A and IL-17F (Aggarwal et al.,
2003; Leppkes et al., 2009). Several genome-wide association
studies have identified a number of genetic variants in the genes
encoding IL23R, IL12A (IL-12p40), JAK2, and STAT3 as inde-
pendent risk (or protective) factors for both ulcerative colitis
(UC) and Crohn’s disease (CD) (Barrett et al., 2008). So far,
a decreased responsiveness of T cell populations to IL-23
is conferred by the presence of a single rare coding variant
(R381Q, rs11209026) in the IL23R gene that is associated with
decreased susceptibility for IBD (Sarin et al., 2011). Although
the link between disease protection and a loss-of-function
variant in IL-23 signaling is compelling, it is worth noting that
the exact functional role of IL-23R signaling in intestinal homeo-
stasis has not been defined yet, and several conundrums remain.
First, IL-23R activation in mucosal immune cells is a pivotal
inducer of the cytokine IL-22, a member of the IL-10 family.
IL-22 has been shown to exert protection against intestinal
inflammation in either adoptive transfer, chemically induced, or
infectious models of colitis (Sugimoto et al., 2008). Therefore,
therapeutic inhibition of pro-inflammatory IL-23R signaling may
also lead to downregulation of IL-22-dependent signals with
unclear consequences.
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Second, high susceptibility to experimental colitis was de-
monstrated in a mouse model with genetic ablation of IL23p19
(Becker et al., 2006). The paradoxical finding has been attributed
to a direct cross-regulation of IL12p35/p40. Importantly, all find-
ings reported so far have concentrated on the role of direct IL-23
signaling in leukocytes, although recent evidence points to a role
of IL-23 signaling in epithelial cells types (Hasnain et al., 2014). In
a previous study, we found IL-23R to be expressed in the intes-
tinal epithelium of normal subjects and IBD patients (Raelson
et al., 2007). Here we report that intestinal epithelium-specific
deletion of the Il23r gene renders mice susceptible to experi-
mental colitis by impairing IL-22-driven protective mucosal im-
munity against flagellated commensals.
RESULTS
Il23RDIEC Mice Show Exacerbated Morbidity and
Associated Mortality in Experimental Colitis
To initially test the ability of IL-23 to elicit a signal in intestinal
epithelial cells in vitro, ModeK cells were stimulated with recom-
binant Il-23 (100 ng/ml), and STAT3 phosphorylation and target
gene induction were assessed by western blot and real-time
PCR, respectively. The experiments revealed a moderate in-
crease in phosphorylation of STAT3 after 30 min as well as a
slight (compared with the effect of Il-22, which was tested in par-
allel) but significant induction of the S100a9mRNA after 6 hr. Un-
der baseline conditions, Il23rmRNA is present at very low levels
in purified murine intestinal epithelial cells, which were upregu-
lated 5-fold by induction of colonic inflammation (2% dextran
sodium sulfate [DSS] for 3 days; Figure S1D). Using a lacZ
knockout (KO) reporter mouse, which expresses b-galactosi-
dase contained within the deletion cassette under the endoge-
nous promoter, we further demonstrated that the Il23r promoter
is active throughout the colonic epithelium (Figure S1E).
We generated a conditional allele of the Il23r gene (Il23rflox
mice) (Figure S2A) and crossed Il23rfl/fl mice to C57Bl/6VillinCre
mice to obtain a specific deletion of Il23r in the intestinal epithe-
lium (termed Il23RDIEC hereafter) and corresponding IL-23Rfl/fl
(Il23Rfl) littermates, as depicted in the breeding scheme (Fig-
ure S2C). Continuous genotyping revealed no evidence for aber-
rant germline deletion (Figure S2B). Genotypes were confirmed
using tail, tissue, and fecal DNA genotyping (Figure S2D).
Although Il23rmRNA in purified intestinal epithelial cell fractions
from Il23RDIEC mice was below the detection threshold (Fig-
ure S2E), it was present in Il23Rfl animals at low levels (30-
fold lower compared with lamina propria mononuclear cells).
Furthermore, to test the impaired signaling downstream of
epithelial IL-23R in vivo, we injected 1.5 mg of Il-23 (or PBS as
sham) intraperitoneally (i.p.) and assessed epithelial STAT3
phosphorylation 1 hr later. Only in IL-23-injected colonic epithe-
lial cells in Il23Rfl, but not in Il23RDIEC, mice could a significant in-
crease of nuclear pSTAT3 immunoreactivity be observed,
thereby providing further evidence for direct epithelial IL-23R
activity, which is inactivated in Il23RDIEC mice (Figures S1F and
S1G).
Macromorphological and histological analysis of the small and
large intestine of Il23RDIEC mice did not reveal any spontaneous
abnormalities apart from a slight reduction in goblet cells (Fig-
ure S3), as reported earlier for the constitutive knockout (Ben-
ham et al., 2014).
When Il23RDIECmicewere exposed to chronicDSS (Wirtz et al.,
2007), fulminant colitis was observed inDSS-treated Il23rDIEC an-
imals based on clinical and histological assessment (Figure 1).
The survival rate of mutant animals declined to 50% in Il23RDIEC
mice compared with 100% survival of Il23Rfl mice (Figure 1B).
Lower numbers of proliferating epithelial cells shown by bromo-
deoxyuridine (BrdU) labeling (Figures 1E and 1F) and reduced
expression of the Reg3g and Reg3b transcripts of proliferation-
associated markers of STAT3 activation in intestinal epithelial
cells (IECs) (Figure 1I) were present in inflamed colon tissue of
Il23RDIEC mice compared with Il23Rfl littermates. The results
were phenocopied in an additional DSS protocol (Wirtz et al.,
2007) with longer treatment cycles (Figure S4), together demon-
strating an unexpected protective role of epithelial IL-23R
signaling against intestinal inflammation.
Epithelial IL-23R Signaling Controls the Abundance of
Flagellated Intestinal Bacteria
To determine the effect of epithelial Il23R signaling on gut micro-
biome composition, we performed 16S rDNA profiling of Il23R-
DIEC and Il23Rfl feces before and after DSS treatment. Principle
coordinate analysis (PcoA) on Bray Curtis distances revealed
four distinct clusters (Figure 2A) based on genotype and treat-
ment. At higher taxonomical levels, the major bacterial phylum
Firmicutes (Figure S5) showed a significantly increased abun-
dance in naive (p = 0.010) and DSS-treated (p = 0.041) Il23RDIEC
mice compared with control littermates. Interestingly, overall
mostly flagellated bacterial groups (e.g., Lachnospiraceae,
Helicobacter, Escherichia/Shigella, Clostridium groups) were
more prevalent in Il23RDIEC mice with further expansion upon
DSS treatment (Figure 2B). Functional metagenomic prediction
using the Phylogenetic Investigation of Communities by Recon-
struction of Unobserved States (PICRUSt) algorithm (Langille
et al., 2013) inferred a significant increase of genes assigned to
flagellar assembly pathways in Il23RDIEC compared with Il23Rfl
mice at baseline and after DSS treatment (Figure 2C). Using a
HEK-Blue Toll-like receptor (TLR)-5 reporter assay (Cullender
et al., 2013), we indeed confirmed an increased abundance of
biologically active flagellin in Il23rDIEC compared with Il23rfl feces
in response to DSS treatment (Figure 2D). Importantly, co-hous-
ing Il23RDIEC mice with an excess of Il23Rfl littermates could cor-
rect disease activity and flagellar expansion, indicating that
altered microbiota significantly contributes to the increased dis-
ease risk of Il23RDIEC mice (Figures S5B and S5C).
Epithelial IL-23 Signaling Licenses Mucosal IL-22
Production
The intestinal epithelium interacts with immune cells that criti-
cally contribute to tissue regeneration by producing IL-22 (Sanos
et al., 2011). We thus hypothesized that altered mucosal IL-22
levels may contribute to the disease risk in Il23RDIEC mice.
Indeed, ex vivo stimulation with IL-23 led to strong IL-22
mRNA upregulation (Figure 3A) in crude small intestinal crypts
prepared from Il23Rfl animals, which was significantly attenu-
ated in crypts from Il23RDIECmice. Known IL-22-expressing cells
in the gut consist of a heterogeneous cell population comprising
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Th17 cells, innate-type immune cells (e.g., natural killer [NK]
cells, innate lymphoid cells) (Buonocore et al., 2010; Cox et al.,
2012) and neutrophilic granulocytes (Zindl et al., 2013). Because
isolated splenocytes showed indistinguishable IL-22 induction
between Il23Rfl and Il23RDIEC animals (Figure 3C), we asked
whether extravasation of IL-22-producing cells may contribute
to different IL-22 levels in Il23Rfl and Il23RDIEC mice. Because
treatment with the aThy-1 antibody inhibits the extravasation
of leukocytes (including T cells, innate lymphoid cells [ILCs],
and neutrophils) into the lamina propria (Wetzel et al., 2006;
Cox et al., 2012), Il23Rfl and IL23RDIEC mice were treated for 2
consecutive days with 100 or 200 mg of a Thy-1 antibody (clone
T24/31), and a significant reduction of CD3+ lymphocytes (Fig-
ure 3D) as well as neutrophils (Gr1+, data not shown) was
observable. IL-23-induced Il-22 expression was blunted in prep-
arations derived from animals that underwent aThy-1 adminis-
tration at a high dose, regardless of their genotype (Figure 3E),
demonstrating that epithelial cells are not a direct source of IL-
22 in response to IL-23.
Subsequently, we analyzed the effect of aThy-1 treatment as
an in vivo model to reduce the mucosal IL-22 level in DSS-
induced colitis (Cox et al., 2012). Il23Rfl and Il23RDIEC mice
were treated prior to induction of DSS colitis (2%) and then every
3 days with 200 mg aThy-1 (Il23Rfl +aThy1; Il23RDIEC + aThy1) or
an immunoglobulin G (IgG) (Il23Rfl, Il23RDIEC) control (clone LTF-
2) (Figure 3H). Il23RDIEC animals treated with aThy1 antibody
became moribund shortly after induction with the 2% DSS
regimen, as determined by a dramatic weight loss over the first
10 days, compared with aThy1-treated Il23Rfl mice (Figure 3F).
This was accompanied by impaired intestinal proliferation
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Figure 1. Increased Lethality and Disease Activity in Il23RDIEC Mice in Chronic Intestinal Inflammation
Colitis was induced by cyclic administration of 2% DSS (n = 10 male animals/group).
(A and B) Weight loss (A) and overall survival (B) were monitored every other day until day 30.
(C) Representative histologies (H&E) of DSS-treated Il23rDIEC and Il23rfl mice on day 30.
(D) The histological score displays the combined score of inflammatory cell infiltration and tissue damage.
(E) Colonic sections from Il23rDIEC and Il23rfl mice were immunostained with antibodies for BrdU.
(F) Positively stained cells were counted per high-power field (HPF, 4003).
(G) The columns represent the median of the colon length obtained from 10 animals/group postmortem on day 30.
(H) Overall disease activity index on day 30.
(I) Colon transcript levels of STAT3-dependent proliferation-associated Reg3b and Reg3g mRNA in Il23rDIEC (n = 10 males) and IL23Rfl (n = 10 males) mice
(qRT-PCR).
Significance was determined using two-tailed Student’s t test and is expressed as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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because the length of the BrdU+ epithelial lining (Figures 3I and
3J) and the number of BrdU+ cells per crypt (Figures 3K and 3L)
were both reduced in Il23RDIEC mice, which was further deterio-
rated by aThy-1 treatment. In line with previous reports on IL-22-
deficient mice (Kreymborg et al., 2007; Zheng et al., 2008),
aThy-1 treatment in Il23RDIEC mice increased the abundance
of flagellated (54.38% in Il23RDIEC and only 39.41% in Il23Rfl
mice) bacterial groups (Figure 3G).
To demonstrate the direct role of IL-22 in the setting, mice
were pretreated with aThy-1 prior to DSS administration as
described above. aThy-1-treated Il23RDIEC mice were then
either supplemented with PBS (+PBS) or recombinant (rec.) IL-
22 (+IL-22) every other day and sacrificed on day 10. Notably,
exogenous IL-22 completely rescued DSS-induced weight loss
(Figure 4A), increased colon length (Figure 4D), reduced the
abundance of flagellated bacteria (data not shown), and
improved wound healing (as measured by BrdU staining and
statistical assessment of the BrdU+ area) (Figures 4B and 4C),
indicating that lack of IL-22 is indeed a decisive element for
the observed phenotype in Il23RDIEC mice. The findings indicate
that coordination of both the epithelial renewal and the compo-
sition of the microbiota relies on the presence of functional IL-
23R in intestinal epithelial cells, which influences optimal
mucosal IL-22 secretion.
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Figure 2. Epithelial IL-23R Controls Microbial Expansion of Flagellated Bacteria in DSS Colitis
(A) PcoA of 16S rDNA sequences was performed on Bray Curtis distance matrices calculated on log-transformed species level (97% similarity) operational
taxonomic unit (OUT) abundance data. p Values were generated by NPMANOVA.
(B) Abundances of dominant bacterial groups (genus level) before and after DSS treatment in the feces of Il23rfl and Il23rDIECmice according to inferred flagellation
status (flagellated, non-flagellated, or unknown; see the Supplemental Experimental Procedures for details) in response to DSS.
(C) Bar plot showing the relative proportion of genes assigned to flagellar assembly pathways in Il23rfl and Il23rDIEC animals at baseline and after DSS treatment
(PICRUst algorithm). The median, lower, and upper quartiles are shown. Asterisks indicate significant differences (one-way ANOVA followed by Tukey-Kramer
multiple comparison test and Welch’s test for two groups (*p < 0.05). See the Supplemental Experimental Procedures for details regarding phylogenomic
analyses.
(D) Load of fecal flagellin measured in Il23rfl and Il23rDIEC mice before and after induction of colitis asmeasured by TLR5 reporter assay (HEK Blue cells) (Cullender
et al., 2013). Data are representative of minimum of n = 3 male animals per group.
Cell Reports 16, 2208–2218, August 23, 2016 2211
Intestinal Epithelial IL-23R Activation Induces Reg3b
Expression
We next addressed the potential mechanism that mediates the
influence of epithelial IL-23R deficiency on IL22 production by
leukocytes. From other studies, which showed direct activation
effects on myelomonocytic cells (Lo¨rchner et al., 2015), we
postulated that the C-type lectin Reg3b, a known STAT3 target
gene in intestinal epithelial cells could be a decisive epithe-
lium-derived co-factor to modulate IL-22 expression.
Reg3b expression was already significantly lower in small in-
testinal and colonic crypts from Il23RDIEC mice compared with
Il23Rfl animals at baseline (Figure 5A) and was further induced
in epithelial cells upon DSS colitis in an IL-23-dependent manner
in Il23Rfl but not in Il23RDIEC animals (Figure 5B). Reg3b could be
directly induced in epithelial cells upon i.p. injection with recom-
binant IL-23 in Il23Rfl but not Il23RDIEC mice (Figure 5C), and in-
duction was mediated by epithelial STAT3, because STAT3DIEC
mice failed to upregulate Reg3b in the colon epithelium
compared with their STAT3fl littermates (Figure 5D). As an
endogenous strong inducer of IL-23 (Kinnebrew et al., 2012),
we further employed i.p. injection of the TLR5 ligand flagellin,
which also led to upregulation of epithelial Reg3b in Il23Rfl ani-
mals (Figures S6A and S6C) but not in Il23RDIEC mice. Notably,
this regulation pattern induced by the endogenous flagellin/IL-
23 model also coincided with differential IL22 mRNA and protein
induction (Figures S6A and S6B). The failure to upregulate IL22
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Figure 3. Epithelial Signaling Licenses IL-22 Production
(A–C) Crude epithelial crypt preparations from the small intestine (A), colon (B), and primary splenocytes (C) from untreated mice were isolated and stimulated for
3 hr with IL-23 (50 ng/ml), and IL-22 mRNA levels were investigated by real-time PCR. Data are representative of a minimum of 3 animals/genotype and
experiment.
(D) Depletion of leukocytes using anti Thy-1 antibody treatment of 100 or 200 mg (T24/31) per mouse 2 days before crypt isolation. Note that such preparations
contain associated leukocytes. The effect of the Thy-1 antibody was confirmed by FACS staining of small intestine lamina propria CD3+ cells.
(E) Isolated cell fractions were stimulated for 3 hr with IL-23 (50 ng/ml), and gene expression of IL-22 was assessed.
(F) Weight loss was monitored from day 3 every day until day 10.
(G) Increased abundance of flagellated bacteria upon aThy-1 administration in Il23RDIEC mice.
(H) Colitis was induced by administration of 2%DSS in the following groups: Il23Rfl (n = 6; 3 male [m], 3 female [f]), Il23RDIEC (n = 7; 4m, 3 f), Il23Rfl +aThy1 (n = 5; 3
m, 2 f), and Il23RDIEC + aThy1 (n = 5; 4m, 1 f). Anti-Thy-1 administration occurred 48 hr prior to DSS induction, on day 0, and then every third day by injection (i.p.) of
200 mg aThy-1 or IgG control.
(I and K) Colon Swiss rolls from Il23Rfl, Il23RDIEC, Il23Rfl +aThy1, and Il23RDIEC + aThy1 mice were immunostained with antibodies for BrdU. Representative
pictures are shown with red lines indicating the area of BrdU absent cells in the colon mucosa (I) or the number of BrdU+ cells per crypt (L).
(J and L) Statistical assessment of intact BrdU+ mucosa (see Experimental Procedures) (K) and BrdU+ cells per crypt (M) in colon Swiss rolls reveals a dramatic
reduction of proliferation in Il23RDIEC and Il23RDIEC + aThy1 mice
Significance was determined using two-tailed Student’s t test and is expressed as the mean ±± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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upon flagellin stimulation was not observable in mixed spleno-
cyte cultures from Il23RDIEC mice, thus rendering a systemic
TLR5 signaling defect unlikely (data not shown).
To rule out an indirect role of autocrine IL-22 as a Reg3b
inducer, freshly isolated epithelial cells from wild-type (WT) ani-
mals were stimulated with IL-23 or IL-22 in the presence or
absence of a neutralizing aIL-22 antibody for 3 hr. IL-23 and
IL-22 both induced expression of Reg3b in intestinal epithelial
cells, whereas only IL-22- but not IL-23-induced Reg3b expres-
sion was blocked by the neutralizing aIL-22 antibody (Figure 5E).
Last, intestinal organoids (Figure 5F) from Il23RDIEC and Il23Rfl
(Sato et al., 2009) mice were stimulated with IL-23 for 24 hr,
and mRNA transcript levels of Reg3b showed significant epithe-
lial Reg3b expression in organoids derived from Il23Rfl but not
Il23RDIEC cultures (Figure 5G). IL-22 was not detectable, again
excluding autocrine IL-22 effects on Reg3b expression (Fig-
ure 5H). These data demonstrate that IL-23 induced Reg3b in in-
testinal epithelial cells via epithelial cell-expressed IL-23R.
Systemic Reg3b Administration Protects Il23RDIEC Mice
from DSS-Induced Colitis by Restoring IL-22 Production
and Recruitment of Neutrophils
We hypothesized that, if indeed Reg3b derived by epithelial cells
is important for the observed phenotype in Il23RDIEC mice, then
systemic administration of Reg3b should protect Il23RDIEC
mice from colitis and influence IL-22 production within the in-
flamed mucosa. Therefore, colitis was induced by 2% DSS,
and Il23RDIEC mice received either PBS or rec. Reg3b intraperi-
toneally every other day for 10 days at a dose far below the con-
centrations that have been shown to have a direct effect on mi-
crobiota when applied luminally in earlier studies (Zheng et al.,
2008). Systemic Reg3b treatment significantly improved DSS-
induced body weight loss (Figure 6A), reconstituted epithelial
proliferation (Figures 6B and 6C), and increased local production
of IL-22 in Reg3b-treated colon explant cultures (Figure 6F).
Given that mucosal IL-22 secretion negatively regulates the
expansion of flagellated b-proteobacteria, we next analyzed
the bacterial composition of the fecal microbiota using 16S
rRNA sequencing. A Bray Curtis PcoA plot showed significant
(nonparametric multivariate ANOVA [NPMANOVA], p = 0.0089)
differentiation between untreated and Reg3b-treated Il23RDIEC
mice (Figure 6G), and systemic Reg3b treatment resulted in a
significant decrease of flagellated bacteria in the colonic feces
of Il23RDIEC mice (Figure 6H).
Becausewe had excluded the possibility of a direct synergistic
effect of Reg3b stimulation on IL-23-induced IL22 expression
by co-stimulation experiments in crude crypt preparations
(data not shown), we next tested the hypothesis whether endog-
enous Reg3b could serve as a chemoattractant principle for IL-
22-producing cells also in the intestine because expression of
Reg3b was recently described to control the accumulation of
activated immune cells in myocardial ischemia (Lo¨rchner et al.,
2015). Indeed, Il23RDIEC mice exhibited reduced numbers of
Thy-1+, CD3+, and CD4+ cells in the small intestinal lamina prop-
ria compared with their Il23Rfl littermates under baseline condi-
tions (Figures S7A–S7C). We specifically observed diminished
numbers of neutrophilic granulocytes in the colonic lamina prop-
ria, as indicated in fluorescence-activated cell sorting (FACS)
A B
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Figure 4. IL-22 Rescues Thy-1-Treated Il23RDIEC Mice through Restoration of Epithelial Regeneration
DSS colitis and aThy-1 administration were induced in Il23RDIEC + IL-22 (n = 5; 3 m, 2 f) and Il23RDIEC + PBS (n = 5; 3 m, 2 f) mice as described in Figure 4. Mice
received 2mg rec. IL-22 on day 0 and every second day or an equivalent volume of PBS.
(A) Weight loss was monitored from day 3 every day until day 10. Colon Swiss rolls from Il23RDIEC + aThy1+ IL-22 and Il23RDIEC + aThy1 + PBS mice were
immunostained with antibodies for BrdU.
(B and C) Representative pictures with red lines indicating the BrdU-negative areas in the colon mucosa (B) and corresponding statistical assessment of BrdU+
areas (proliferative area) (C).
Significance was determined using two-tailed Student’s t test and is expressed as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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staining (Gr-1, Figure S7D) and colon histology of untreated
IL23RDIEC compared with Il23Rfl mice (Figures S7E and S7F).
Neutrophil numbers were notably increased in the lamina propria
of Reg3b-treated Il23RDIEC animals despite the clear anti-inflam-
matory effect of Reg3b treatment (Figures 6D and 6E).
To further test the chemotactic role of Reg3b for immune
cells, WT mice were injected i.p. with PBS or recombinant endo-
toxin-free Reg3b, and peritoneal cells were collected. Cytospin
and FACS analysis of peritoneal cell composition showed a sig-
nificant influx of neutrophils 6 hr after Reg3b administration,
whereas the level of macrophages, eosinophils, and basophils
remained unchanged (Figures 6J–6O and data not shown). In
line with a positive influence of Reg3b on chemotaxis, Cxcl1
production was also increased in peritoneal fluids (Figure 6P)
and sera (Figure 6Q) after Reg3b treatment. Finally, we could
show that Reg3b KO mice produce less IL-22 in response to
flagellin compared with similarly treated WT littermate controls
(Figure 6I).
Taken together, these data provide evidence for a mechanism
involving IL-23R-dependent epithelial Reg3b expression, which
is needed for adequate attraction of IL-22 secreting cells,
most notably neutrophils. In addition to a direct regenerative
effect, this mechanism may help to control colonic microbiota
composition.
DISCUSSION
Intestinal homeostasis requires a balanced interplay of a
plethora of cell types. A growing body of evidence highlights
the key role of transducing tonic signals from commensal
bacteria into cytokine-mediated epithelial regenerative pro-
grams (Veldhoen et al., 2008; Martin et al., 2009; Mielke et al.,
2013; Leung et al., 2014). So far, the epithelium has been mainly
thought to ‘‘passively’’ receive cytokine signals and transduce
them into an antimicrobial and regenerative response that is
known to be dependent on STAT3 (Pickert et al., 2009).
Here we demonstrate that IL-23-dependent activation of the
intestinal epithelium serves as a crucial modulatory factor toward
an orchestrated immune response from epithelial cells that sub-
sequently control antimicrobial and regenerative processes in
the inflamed mucosa.
It must be noted that the expression levels of IL-23R in intes-
tinal epithelial cells are low compared with immune cells.
Although we provide evidence for direct signaling and IL-
23R-dependent target gene expression in IECs and Il23r
mRNA upregulation during intestinal inflammation, the different
expression patterns between the epithelial compartment and
immune cells warrant an adequate discussion of the potential
pitfalls of the model. We have controlled for the precision of
the Cre excision by the villin-Cre line in Il23RDIEC mice both
by demonstrating the genomic deletion, which is only present
in IECs but not in other cellular compartments, as well as by
showing that mixed immune cells (splenocytes) from Il23RDIEC
mice respond functionally normal to IL-23 stimulation. In an
independent cross for which we used the lysM-Cre line,
deletion of the Il23r gene in the myeloid compartment caused
a clear impairment of IL-23-dependent target gene expres-
sion in CD11c+ cells (unpublished data), demonstrating that
A
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Figure 5. Epithelial IL-23R Orchestrates Reg3b Expression
(A) Small intestinal and colon crypts were isolated, and gene expression of Reg3b was assessed. Data are representative of at least 3 animals/genotype.
(B) Expression of Reg3b in response to DSS induction was quantified in colonic epithelial cells isolated after 3 days of 2% DSS colitis induction.
(C and D) Il23rfl and Il23rDIEC (C) and STAT3fl and STAT3DIEC (D) animals were injected with IL-23 (1.5 mg) for 2 hr. Colon transcript levels of Reg3bwere assessed
by real-time PCR.
(E) Freshly isolated epithelial cells from WT animals were stimulated with IL-23 (50 ng/ml) or IL-22 (50 ng/ml) in the presence or absence of neutralizing aIL-22
antibody (1 mg/ml) for 3 hr. Transcript levels of Reg3b were assessed by real-time PCR.
(F) Cultivation of intestinal organoids from Il23rfl and Il23rDIEC mice.
(G and H) Organoids were stimulated for 24 hr with IL-23 (100 ng/ml), and Reg3b (G) and IL-22 (H) mRNA expression was determined by real-time PCR.
Significance was determined using two-tailed Student’s t test and is expressed as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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cre-mediated excision is principally also able to impair IL-23R-
dependent signals in another genetic model. The employed
villin-cre line has been characterized extensively in many
studies, making an inadequate activation of the promoter in
specific immune cells extremely unlikely as the underlying
cause of the phenotype. We thus think that, despite the low
level of expression, it is justified to assume that the observed
protective effects are directly linked to an activation of IL-
23R on intestinal epithelial cells.
We report that Il23RDIECmice rapidly succumb to chronicDSS-
induced colitis because of reduced wound healing and impaired
IL-22-mediated protective immune responses. Il23RDIEC animals
significantly differ in their composition of the gut microbiota with
expansion of flagellated bacterial genera. Interestingly, the
expansion of flagellated bacterial taxa became even more
pronounced upon DSS challenge or inhibition of leukocyte
extravasation and correlated with the severity of colitis. These
observations agree with findings that the abundance of
A
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Figure 6. Systemic Reg3b Substitution Rescues Il23RDIEC Mice by Increasing Local IL-22 Production
DSS colitis was induced in Il23RDIEC + Reg3b (n = 5; 3 m, 2 f) and Il23RDIEC + (n = 9; 5 m, 4 f) mice as described above. Mice received 2 mg rec. Reg3b or an
equivalent volume of PBS i.p. on day 1 and every second day.
(A) Weight loss was monitored from day 3 every day until day 10.
(B) Colon Swiss rolls from Il23RDIEC and Il23RDIEC + Reg3bmice were immunostained with antibodies for BrdU. Representative pictures are shown, with red lines
indicating the BrdU-negative area.
(C) Representative pictures of colonic sections stained with anti-BrdU+ antibody.
(D and E) Representative H&E pictures of colon showing increased neutrophil influx in Reg3b-treatedmice (D) and statistical evaluation of counted neutrophils per
HPF (E).
(F) IL-22 ELISA of colon explants from Il23RDIEC+Reg3b versus Il23RDIEC mice.
(G) Principle coordinate analysis (Bray Curtis distance matrices) of fecal flora obtained by 16S rDNA V4 sequencing from Il23RDIEC+Reg3b versus Il23RDIEC
animals after DSS treatment (see the Supplemental Experimental Procedures for details).
(H and I) Abundances of dominant bacterial groups (genus level) after DSS treatment in the feces of Il23RDIEC+ Reg3b versus Il23RDIEC mice according to the
flagellatin status (flagellated, non-flagellated, or unknown) in response to DSS (H), IL-22 ELISA fromWT or Reg3b KO explants after stimulation with 1 mg ultrapure
flagellin for 2 hr i.p. (I).
(J–Q) Peritoneal exudates of five wild-type mice were harvested 6 hr after intraperitoneal injection of either sterile saline solution (K) or 100 mg/kg of purified,
endotoxin-free Reg3b (N), and relative numbers of neutrophils ormacrophageswere assessed by cytospin (J andM), or Gr-1 and F4/80 staining was quantified by
FACS analysis (K, L, N, and O). Representative flow cytometric analyses (K and N) of peritoneal cell populations and statistical analysis (L and O) show that Reg3b
triggers the influx of neutrophils. Also shown is an ELISA on the indicated cytokines on peritoneal fluid (P) and sera (Q) after Reg3b stimulation as described above.
Significance was determined using two-tailed Student’s t test and is expressed as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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flagellated intestinal bacteria is a critical factor for the severity of
experimental colitis (Rhee et al., 2005; Vijay-Kumar et al., 2007;
Ivison et al., 2010). One may therefore presume that the expan-
sion of flagellated taxa in Il23RDIEC mice may result from the
lack of flagellin-induced IL22 secretion, which is known to require
endogenous IL-23 from dendritic cells (Kinnebrew et al., 2012).
Recent studies in Il22/ mice (Zenewicz et al., 2013; Behnsen
et al., 2014) and our own data reconstituting Il23RDIEC mice
with exogenous IL-22 corroborate this hypothesis. As in many
other DSS-driven models, the altered microbiota augments the
inflammatory phenotype observed in Il23RDIEC mice, whereas
co-housingwith an excess of floxed littermates rescues Il23RDIEC
mice from disease risk.
Our data indicate that epithelial IL-23R signaling exerts pivotal
control over mucosal IL-22 secretion through a newly described
mechanism. Interestingly, our screening for potential chemo-
kines secreted by the epithelium revealed that IL-23-dependent
secretion of the c-type lectin Reg3b is likely to act as a paracrine
factor amplifying IL-22 production in the lamina propria. The few
studies on the effect of Reg3 proteins on intestinal mucosal im-
munity describe mainly a direct antimicrobial activity because
mice deficient in Reg3g display a different mucus architecture
(Vaishnava et al., 2011), and luminal application of high doses
of recombinant Reg3g seems to reduce colonization withSalmo-
nella (van Ampting et al., 2012). However, the exclusive direct
antimicrobial effect is much less clear for Reg3b. The fact that
genetic ablation of Reg3b in mice leads to prolonged coloniza-
tion with Y. pseudotuberculosis in ileal Peyer’s patches without
affecting luminal bacterial levels indicates a potential effect of
Reg3b beyond its presence in the intestinal mucus (Dessein
et al., 2009; van Ampting et al., 2012). A very recent report in
the ischemic heart points toward a role of Reg3b in mediating
macrophage trafficking to control protective immune cell infiltra-
tion into the affected heart tissue (Lo¨rchner et al., 2015). Further-
more, Reg3b is skewing macrophage polarization through an
unknown mechanism (Gironella et al., 2013).
Although we could not demonstrate a direct synergistic effect
of Reg3b on IL-23-mediated induction of IL22 expression in vitro,
we show by intraperitoneal injection that the protein acts as a
chemoattractant for neutrophils. Interestingly, neutrophils have
recently been reported to serve as a source for mucosal IL-22
in DSS-induced inflammation (Zindl et al., 2013). In line with
the idea that epithelium-derived Reg3b could control mucosal
levels of IL22-producing neutrophils, intraperitoneal Reg3b
administration attenuated the increased clinical susceptibility
to DSS-induced inflammation in Il23RDIECmice. Under such con-
ditions, Reg3b injection clearly upregulated neutrophil numbers
in the lamina propria and restored IL-22-secretion in Il23RDIEC
animals.
Thereby we demonstrate that IL-23R-dependent Reg3b trig-
gers an influx of IL-22-producing immune cells. It remains to
be determined whether the alarmin Reg3b may dictate the
recruitment of only one or also other IL-22-producing cell types;
however, our data clearly point to neutrophils as a plausible
candidate. It also remains to be determined whether Reg3b is
actively secreted on the basolateral side in the physiological
setting or whether it may only enter the lamina propria via epithe-
lial barrier defects. Taken together, we could show that the
epithelial IL-23R licenses mucosal IL-22 production and serves
as a critical factor orchestrating protective mucosal immune re-
sponses in the context of microbiota-fueled inflammation. These
findings have important implications for future therapeutic devel-
opments in chronic inflammatory diseases because the rationale
of IL-23 neutralization is the dampening of TH17 cell activity.
However, in clinical settings like IBD, where IL-22 secretion
might be an important protective factor, proregenerative func-
tions of IL-23 on epithelial cells should be kept in mind.
EXPERIMENTAL PROCEDURES
Mice
Weight- and gender-matched mice (genetic background C57Bl6JxSv129,
backcrossed for at least six generations) were used at an age of 8–12 weeks
for all experiments. For DSS experiments, the indicated numbers (minimum
n = 5 per genotype) of animals were employed. Il23Rfl/fl mice were generated
by targeted insertion of LoxP sites flanking exon 4 of the IL23R gene (Geno-
way). Villin-Cre animals (strain B6.SJL-Tg(Vil-cre)997Gum/J) were purchased
from Jackson Laboratory. Conditional knockout of Il23R in the intestinal
epithelium was established by crossing Villin-Cre with Il23Rfl/fl mice, resulting
in Il23RDIEC or IL23Rfl. It has been well established that this knockout, apart
from some expression of the transgene in renal tubuli, is specific for the intes-
tinal epithelium and does not involve immune cells in the intestine (El Marjou
et al., 2004).STAT3fl/fl and STAT3DIEC mice were provided by ChristineWatson
(Cambridge University). Reg3b WT and Reg3b KO mice were kindly provided
by Stephen P. Hunt (University College London). The b-galactosidase reporter
mouse (Il23R knockin/knockout mouse [(il23rtm1a (EUCOMM)Wtsi mouse
with lacZ cassette]) was kindly provided by the EUCOMM Consortium. Mice
were maintained in a 12-hr light-dark cycle under standard conditions and
were provided with food and water ad libitum. Procedures involving animal
care were conducted according to national and international laws and policies
and with appropriate permission. Appropriate permission was given by the
local animal safety review board of the federal ministry of Schleswig Holstein.
Antibodies and Reagents
Murine aThy-1 (clone T24/31) was purchased from BioXcell. Flagellin (FLA-ST
ultrapure) was purchased from InvivoGen. Recombinant murine Reg3b was
purchased from R&D Systems. Recombinant murine IL-22 was purchased
from PeproTech, and recombinant murine IL-23 was purchased from
BioLegend.
FACS
Flow cytometry was performed on a FACSCalibur (BD Biosciences), and data
were analyzed using CellQuest software (BD Biosciences) using standard pa-
rameters and antibodies (details can be found in the Supplemental Experi-
mental Procedures).
Isolation of Primary Cells and Cultivation of Intestinal Organoids
Murine intestinal epithelial cells and lamina propria cells were isolated using
the Hank’s balanced salt solution (HBSS)-EDTA method followed by enzy-
matic digestion. Mouse intestinal organoids were cultivated as described
before (Sato et al., 2009). For details, see the Supplemental Experimental
Procedures.
Induction of Colitis, Determination of Clinical Scores, and Histology
For chronic colitis induction, mice were supplied with 2% of DSS (molecular
mass, 40 kDa; TdB Consultancy) dissolved in drinking water for 5 days, fol-
lowed by 5 days of regular drinking water. The disease activity index (DAI)
was obtained as described previously (Siegmund et al., 2001). Consumption
of drinking water was measured daily. A high-resolution mouse video endo-
scopic system was used on day 30 of the experiment (Karl Storz AIDA VET),
and endoscopic scores were obtained as described previously (Wirtz et al.,
2007). For induction of short colitis, mice were supplied with 2% DSS dis-
solved in drinking water for 3 days and sacrificed immediately for intestinal
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epithelial cell isolation as described elsewhere (Pickert et al., 2009). Histopath-
ological analyses were performed according to standard methods (see the
Supplemental Experimental Procedures for details).
Colon Culture
Colons were washed in cold PBS supplemented with penicillin and strepto-
mycin (Gibco) and cut longitudinally. Four segments of 0.5-cm length were
cultured in 24-well flat-bottom culture plates in RPMI 1640 medium (Gibco)
for 24 hr at 37C. Supernatants were analyzed for IL-22 concentration using
an IL-22 ELISA kit according to the manufacturer’s protocol(PeproTech).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (version 4.0) for
Windows software (GraphPad ). Statistical significance was evaluated by
Mann-Whitney U test for nonparametric data or Student’s t test for parametric
data unless indicated otherwise. p values less than 0.05 were considered sta-
tistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2016.07.054.
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